Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 13
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
13| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8648097 | OMLONTIomidenepag isopropyl | substance, product | Oct 2029 |
| 8685986 | OMLONTIomidenepag isopropyl | product | Oct 2029 |
| 10179127 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| 10702511 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| 10765750 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| 11197849 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| 11793798 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| 12295946 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| 9415038 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| RE48183 | OMLONTIomidenepag isopropyl | product | Jan 2035 |
| 10774072 | OMLONTIomidenepag isopropyl | substance | Jun 2035 |
| 12290511 | OMLONTIomidenepag isopropyl | use | Dec 2038 |
| 11666563 | OMLONTIomidenepag isopropyl | use | Jul 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| OMLONTIOMIDENEPAG ISOPROPYL | NCE New chemical entity | Sept 2027 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Omlonti | omidenepag isopropyl | solution/ drops, ophthalmic | 84826-002NDA |
Enquiry
Common questions
- Is Ocuvex Therapeutics, Inc. FDA approved?
- Ocuvex Therapeutics, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Ocuvex Therapeutics, Inc. make?
- 1 product is listed under Ocuvex Therapeutics, Inc. in the openFDA NDC Directory, most often as solution/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.